Alvogen has an innate passion for performance and growth and has become a major player driving change in this ever-changing industry. Our passionate team is committed to continue growing our business around the world and build a leading generic pharmaceuticals player. A unique portfolio of high-quality and difficult-to-make pharmaceutical products fuels our targeted growth strategy.
"Our vision is to become the preferred partner by setting a new standard for the future of pharma.”
Leading global company
By 2025 this will have inspired us in becoming a leading global generic pharmaceutical company and a preferred partner that continuously provides a meaningful difference in the life of the people we serve.
The world is constantly changing all around us and the traditional generics models are being challenged. Alvogen is ready to move swiftly and react to a rapidly changing environment and tough competitors.
We are determined to become the preferred partner in all our markets and have a clear vision on how we want our company to develop and grow, which is outlined in our strategic roadmap that outlines our customer commitments: The Alvogen STARMAP.
The Alvogen STARMAP
We focus on building a well targeted and profitable portfolio in all our markets to serve our customers.
We are committed to the highest quality standards for all our products and services.
We continuously focus on providing consistent and reliable high quality service to our customers.
We focus on selecting and retaining the best talent in every field to fuel our success through our performance driven culture.
We are a lean global organization with continuous focus on operational efficiency and cost optimization.
Alvogen has commercial operations in 20 countries, including China, Hong Kong, Iceland, India, Luxembourg, Malaysia, Malta, USA, Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam, as well as regional hubs, manufacturing and R&D capabilities in the U.S. and South Korea.